secwatch / observer
8-K filed March 26, 2026, 7:59 PM ET ticker ENTA CIK 0001177648
litigation confidence high sentiment neutral materiality 0.40

Federal Circuit schedules May 11, 2026 oral argument for Enanta's patent appeal against Pfizer over Paxlovid

ENANTA PHARMACEUTICALS INC

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-125113
form_type
8-K
ticker
ENTA
cik
0001177648
company_name
ENANTA PHARMACEUTICALS INC
filed_at
2026-03-26T23:59:59+00:00
discovered_at
2026-05-14T18:02:34.645985+00:00
generated_at
2026-05-15T08:47:06.626818+00:00
sec_items
["8.01"]
event_type
litigation
sentiment
neutral
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-125113
json_url
https://secwatch.observer/filing/0001193125-26-125113.json
markdown_url
https://secwatch.observer/filing/0001193125-26-125113.md
text_url
https://secwatch.observer/filing/0001193125-26-125113.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1177648/000119312526125113/0001193125-26-125113-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1177648/000119312526125113/enta-20260320.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

OLPX

Olaplex settles derivative suit with $700K in fees and governance reforms; court preliminarily approves

OLAPLEX HOLDINGS, INC. May 29, 2026, 4:17 PM ET litigation Items 8.01, 9.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

MCFT

MasterCraft settles stockholder lawsuit over director removal provision; pays $425k in fees

MasterCraft Boat Holdings, Inc. May 22, 2026, 8:30 AM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

NUWE

Nuwellis settles E.F. Hutton lawsuit for $204K; mutual release, dismissal with prejudice

Nuwellis, Inc. April 24, 2026, 7:59 PM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

ANGO

AngioDynamics files patent infringement suit against Endovascular Engineering over Hēlo Thrombectomy System

ANGIODYNAMICS INC April 23, 2026, 7:59 PM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

NEXT-ChemX Corporation.

NEXT-ChemX dismisses lawsuit against Sparkie Properties; Texas appeals court rules in favor of Sparkie

NEXT-ChemX Corporation. April 20, 2026, 7:59 PM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

MSTR

Strategy settles STRK preferred lawsuit; pays $550K fees, holds 762K BTC

Strategy Inc March 30, 2026, 7:59 PM ET litigation Items 8.01, 7.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

CPRX

Catalyst bench trial for FIRDAPSE patents delayed from March 23 to May 18, 2026

CATALYST PHARMACEUTICALS, INC. March 18, 2026, 7:59 PM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

DFNS

T3 Defense sued by Kingswood Capital over alleged success fee; company denies claims

T3 Defense Inc. March 6, 2026, 6:59 PM ET litigation Items 8.01

same SEC item: 8.01 same event type: litigation similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-125113

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.